Sheila Collins, Ph.D.

Sheila Collins' Research Focus

Related Diseases > Metabolic Diseases, Metabolic Syndrome, Obesity, Type 2 Diabetes

Dr. Collins's laboratory is interested in the biochemical mechanisms that regulate body weight. Activation of the adrenaline receptors, specifically the members of the beta-adrenergic receptor (beta-AR) family, provides the major stimulus for the hydrolysis and release of stored lipids. They are also key drivers of a process called "nonshivering thermogenesis" in brown fat. Brown fat cells are specialized cells rich in mitochondria and largely defined by their ability to express the mitochondrial uncoupling protein UCP1, which allows the dissipation of the proton gradient in the inner mitochondrial membrane to yield heat at the expense of ATP production. 

By understanding the beta-ARs on fat cells, their signal transduction properties and how they are regulated, we hope to be able to find a way to increase energy expenditure in fat in the fight against obesity and the devastating diseases that accompany it, such as diabetes, cardiovascular disease and hypertension.

Sheila Collins' Bio

Sheila Collins, Ph.D., received her B.S. degree with honors in zoology from the University of Massachusetts at Amherst. She then joined Massachusetts General Hospital in Boston and the California Institute of Technology in Pasadena as a research technician working in developmental and molecular biology. Dr. Collins received her doctorate in biochemistry and drug metabolism from the Massachusetts Institute of Technology with Dr. Michael Marletta, and conducted postdoctoral research with Dr. Robert Lefkowitz at Duke University, both of whom are National Academy Science members. Dr. Collins continued her research career at Duke University Medical Center as a faculty member in the Department of Psychiatry and Behavioral Sciences, where she was awarded tenure. She moved to The Hamner Institutes for Health Sciences, helping to develop biomedical research, retaining her Duke faculty appointment. While there, she was named the Hamner Senior Fellow in Endocrine Biology. In 2010, Dr. Collins joined the Diabetes and Obesity Research Center at Sanford-Burnham Medical Research Institute (Orlando, FL), where she is Professor of Metabolic Disease. Dr. Collins has served on numerous review committees and advisory panels for the National Institutes of Health, the American Diabetes Association, American Heart Association and has been an organizer of many national and international scientific meetings. Dr. Collins investigates biochemical mechanisms regulating body weight. Specifically, her lab is deciphering how hormonal signals, such as adrenaline and novel pathways using heart-derived hormones control fat cell metabolism, including how the genes in brown and white adipocytes are controlled to increase energy expenditure and weight loss.
 

Other Appointments

Adjunct Associate Professor, Psychiatry and Behavioral Sciences, Duke University Medical Center
Adjunct Assistant Professor, Department of Medicine, Duke University Medical Center

 

Honors and Recognition

Consulting Editor for the Journal of Clinical Investigation

IM Program

Publications

Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessì-Fulgheri P, Zhang C, Takahashi N, Sarzani R, Collins S
J Clin Invest 2012 Mar;122(3):1022-36
Cao W, Daniel KW, Robidoux J, Puigserver P, Medvedev AV, Bai X, Floering LM, Spiegelman BM, Collins S
Mol Cell Biol 2004 Apr;24(7):3057-67
Johnson SB, Soulos PR, Shafman TD, Mantz CA, Dosoretz AP, Ross R, Finkelstein SE, Collins SP, Suy S, Brower JV, Ritter MA, King CR, Kupelian PA, Horwitz EM, Pollack A, Abramowitz MC, Hallman MA, Faria S, Gross CP, Yu JB
Radiother Oncol 2016 Nov 24;
Collins SL, Stevenson D, Mentasti M, Shaw A, Johnson A, Crossley L, Willis C
Epidemiol Infect 2016 Nov 28;:1-9
Marwick B, Clarkson C, O'Connor S, Collins S
J Hum Evol 2016 Dec;101:45-64